63174 Federal Register / Vol. 62, No. 228 / Wednesday, November 26, 1997 / Notices

commonly used for single sex, single

species carcinogens such as bromoxynil

that are thought to work through

secondary mechanisms. Nevertheless,

the risk assessments filed with this

petition have been performed using

quantitative risk assessment

methodology. Accordingly, the upperbound risk estimate for the general U.S.

population represented by all sources of

bromoxynil exposure, including use of

bromoxynil on up to 10% of the U.S.

treated acreage is approximately 2 ×

10-6.

2. Infants and children. To estimate

acute dietary risk for systemic effects

other than developmental from food

sources, an MOE of 270 was calculated

using 1–day dietary exposure for infants

(the most highly exposed population

group) and a NOEL of 8 mg/kg/day

derived from a 13–week oral toxicity

study in dogs. It is concluded that

reliable data support use of the standard

hundredfold margin of exposure/safety

factor in assessing the risk to children.

The general U.S. population and all

population sub-groups are estimated to

be exposed at a level less than 1 percent

of the bromoxynil RfD of 0.015 mg/kg/

day. Both chronic and acute

assessments show no appreciable

threshold risks to children and the nonthreshold cancer risk is no greater than

negligible. Therefore, there is a

reasonable certainty that no harm will

result to infants and children from

aggregate exposure to bromoxynil.

Two multi-generation rodent

reproduction studies demonstrated that

there were no adverse effects on

reproductive performance, fertility,

fecundity, pup survival, or pup

development. Maternal and

developmental NOELs and LOELs were

comparable indicating no increase

susceptibility of developing organisms.

No evidence of endocrine effects were

noted in any study. It is therefore

concluded that bromoxynil poses no

additional risk for infants and children

and no additional uncertainty factor is

warranted.

F. International Tolerances

There are no Codex tolerances

established for bromoxynil residues,

therefore international compatibility is

not considered to be an issue at this

time.

[FR Doc. 97–30812 Filed 11–25–97; 8:45 am]

BILLING CODE 6560–50–F

ENVIRONMENTAL PROTECTION

AGENCY

[FRL–5927–7]

Proposed Settlement Pursuant to

Section 122(g) of the Comprehensive

Environmental Response,

Compensation, and Liability Act,

Regarding the Sealand Restoration

Superfund Site, Lisbon, New York

AGENCY: Environmental Protection

Agency.

ACTION: Notice of proposed

administrative settlement and

opportunity for public comment.

SUMMARY: In accordance with section

122(i) of the Comprehensive

Environmental Response,

Compensation, and Liability Act of

1980, as amended (CERCLA), 42 U.S.C.

9622(i), the U.S. Environmental

Protection Agency (EPA), Region II,

announces a proposed administrative de

minimis settlement pursuant to section

122(g)(4) of CERCLA, 42 U.S.C.

9622(g)(4), relating to the Sealand

Restoration Superfund Site (Site). The

Site is located on Pray Road in the

Town of Lisbon, St. Lawrence County,

New York. This document is being

published pursuant to section 122(i) of

CERCLA to inform the public of the

proposed settlement and give it the

opportunity to comment. EPA will

consider any comments received during

the comment period and may withdraw

or withhold consent to the proposed

settlement if comments disclose facts or

considerations which indicate that the

proposed settlement is inappropriate,

improper, or inadequate.

The proposed de minimis settlement

between EPA and Westpoint Stevens

Inc., on behalf of former Cluett, Peabody

& Co. (Respondent) has been

memorialized in an Administrative

Order on Consent (Index Number

CERCLA–97–0215). This Order will

become effective after the close of the

public comment period, unless

comments received disclose facts or

considerations which indicate the

Agreement is inappropriate, improper,

or inadequate, and EPA, in accordance

with section 122(i)(3) of CERCLA,

modifies or withdraws its consent to the

Agreement. Under the Order, the

Respondent will be obligated to make

payments to the Hazardous Substance

Superfund in reimbursement of EPA’s

response costs relating to the Site, plus

a premium, based on documented

volumes of substances in EPA’s records

associated with the Site, totaling

$47,676.

Pursuant to CERCLA section

122(h)(1), the Order may not be issued

without the prior written approval of

the Attorney General or her designee. In

accordance with that requirement, the

Attorney General or her designee has

approved the proposed administrative

order in writing.

DATES: Comments must be provided on

or before December 26, 1997.

ADDRESSES: Comments should be

addressed to the U.S. Environmental

Protection Agency, Office of Regional

Counsel, New York/Caribbean

Superfund Branch, 17th Floor, 290

Broadway, New York, New York 10007–

1866, and should refer to: ‘‘Sealand

Restoration Superfund Site, U.S. EPA

Index No. CERCLA–97–0215’’. For a

copy of the settlement document,

contact the individual listed below.

FOR FURTHER INFORMATION CONTACT:

Elizabeth Davis, Assistant Regional

Counsel, New York/Caribbean

Superfund Branch, Office of Regional

Counsel, U.S. Environmental Protection

Agency, 17th Floor, 290 Broadway, New

York, New York 10007. Telephone:

(212) 637–3165.

Dated: November 4, 1997.

William J. Muszynski,

Acting Regional Administrator.

[FR Doc. 97–31137 Filed 11–25–97; 8:45 am]

BILLING CODE 6560–50–P

COUNCIL ON ENVIRONMENTAL

QUALITY

Notice of Meeting; Postponement

SUMMARY: The Council on

Environmental Quality (CEQ) is

postponing a public meeting it had

previously scheduled for December 2,

1997, to discuss development of a

memorandum of understanding on

coordinating environmental response

actions with natural resource restoration

under the Comprehensive

Environmental Response,

Compensation, and Liability Act and

other laws. 62 FR 51660 (October 2,

1997). CEQ intends to reschedule the

meeting for late January or early

February, 1998. CEQ will soon publish

another Federal Register notice

identifying the time, place, and agenda

for the meeting.

FOR FURTHER INFORMATION CONTACT:

Mary Morton at (202) 208–3302.

Bradley M. Campbell,

Associate Director.

[FR Doc. 97–31031 Filed 11–25–97; 8:45 am]

BILLING CODE 3125–01–M